BE at Steady state [Design Issues]

posted by Ahmed meeran – 2006-09-12 08:10 (7230 d 07:35 ago) – Posting: # 249
Views: 13,547

Dear Dr. Helmut

All the regulatory guidlines talks about conducting Bioequivalence study in single dose and at steady state conditions. For which type of drugs conducting a Bioequivalence study at steady state conditions is necessary.

For performing Bioequivalence study at steady state whether the sample size calculation is same as that of single dose study.

If Bioequivalence study is performed at steady state whether it will meet the acceptance criteria with small no of subjects than a single dose study.

Please guide me in these issues

Ahmed

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
298 visitors (0 registered, 298 guests [including 23 identified bots]).
Forum time: 15:45 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5